Genmab logo

Genmab

Differentiated human antibody therapeutics for the treatment of cancer

2981 employees · est. 1999 · Denmark

VS
Planet Biotechnology, Inc. logo

Planet Biotechnology, Inc.

Developing promising antibodies and receptor/ligand-Fc fusion proteins for the treatment and prevention of disease

5 employees · est. 1998

Planet Biotechnology, Inc. is the older company (1999 vs 1998); Genmab is the larger of the two.

Side-by-Side Comparison

Genmab Planet Biotechnology, Inc.
Founded
1999 1998 older
Headquarters
Denmark Not tracked yet
Employees
2981 larger 5
Industry
Biotechnology, Pharmaceutical Biotechnology, Health and Wellness
Funding Stage
IPO Debt Financing
Total Funding
$2.28B $761.00K
Funding Rounds
6 2
Services
Development of Antibody Therapeutics, Pipeline of Medicines, Biotech Research Not tracked yet
Target Customers
Healthcare Professionals, Patients & Care Partners, Investors, Corporate Partners Not tracked yet
Taxonomy
Antibody Therapeutics, Cancer Treatment, Bispecific Antibodies, Antibody-Drug Conjugates, Immune-Modulating Antibodies, Clinical Pipeline, Innovative Medicines, Antibody Innovation, Late-stage Clinical Trials, Biopharmaceuticals, Healthcare Innovation, Unmet Medical Needs, Drug Development Antibodies, Therapeutics, Preventative Medicine, Infectious Diseases, Clinical Trials, Green Plants, Genetic Modification, Receptor-antibody Fusion, Bio-threat Agents, Antiviral Antibodies, Greenhouse Cultivation, Medical Research, Emerging Diseases, Antibody Production
Website
genmab.com planetbiotechnology.com
Genmab logo

About Genmab

Genmab, founded in 1999, is a pioneering international biotechnology company headquartered in Denmark. Renowned for its expertise in antibody innovation, Genmab focuses on developing differentiated human antibody therapeutics aimed at treating cancer and other serious diseases. Through its innovativ...

Planet Biotechnology, Inc. logo

About Planet Biotechnology, Inc.

Planet Biotechnology, Inc. Planet Biotechnology, Inc. is a biotechnology startup focusing on the development of antibodies and receptor/ligand-Fc fusion proteins for the treatment and prevention of diseases. Founded in 1998, the company has made significant strides in the production of plant-made a...

We will tell you when either one moves

BounceWatch watches Genmab and Planet Biotechnology, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Genmab and Planet Biotechnology,... — by email.

Frequently Asked Questions

Genmab — Differentiated human antibody therapeutics for the treatment of cancer. Planet Biotechnology, Inc. — Developing promising antibodies and receptor/ligand-Fc fusion proteins for the treatment and prevention of disease. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Genmab has raised $2.28B while Planet Biotechnology, Inc. has raised $761.00K.
Genmab and Planet Biotechnology, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Genmab with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Genmab on 25 Jun 2026, and Planet Biotechnology, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy